Αποτελέσματα Αναζήτησης
11 Αυγ 2024 · As an anti-inflammatory, methylprednisolone is 5 times as potent as hydrocortisone (cortisol) while demonstrating minimal mineralocorticoid activity. Methylprednisolone diffuses passively across the cellular membrane and binds to the intracellular glucocorticoid receptor.
23 Οκτ 2021 · Abstract. The temporal variations in the pharmacokinetics and pharmacodynamics of methylprednisolone at 8 am versus 4 pm were investigated in six healthy male volunteers. Subjects completed three phases: no drug administration, 20 mg intravenous methylprednisolone at 8 am, and the same dose at 4 pm. Methylprednisolone clearance was 28% greater ...
Within a 24-h interval, two dose fractions of methylprednisolone produce a stronger and more sustained immunosuppressive response than one single bolus dose.
11 Αυγ 2024 · As a systemic corticosteroid, methylprednisolone exhibits anti-inflammatory and immunosuppressive properties, effectively treating endocrine, inflammatory, immunologic, hematologic, and respiratory disorders.
15 Φεβ 2019 · Methylprednisolone (MPL), a corticosteroid of intermediate potency, remains an important immunomodulatory agent for autoimmune diseases. Although sex differences in corticosteroid pharmacokinetics/pharmacodynamics (PK/PD) have been documented in humans, comprehensive preclinical assessments of such differences have not been conducted.
Longer infusion times (2–3 h) ... • Dose alteration of methylprednisolone and dexamethasone may be needed (prednisone and prednisolone not affected to a clinically relevant degree by this interaction) ... For medium doses (2.5-7.5 mg daily), the unadjusted FRAX value can be used, and for low-dose exposure (<2.5 mg daily of prednisolone or ...
1 Δεκ 2021 · Methylprednisolone (MP) is an anti-inflammatory drug approved for the treatment of acute spinal cord injuries (SCIs). However, MP administration for SCIs has become a controversial issue while the molecular effects of MP remain unexplored to date.
